Meghan McCarthy: Closing the Diagnostic Gap in Women with Bleeding Disorders
Meghan McCarthy, Founder of Maternie and MKMV Consulting, shared a post on LinkedIn:
“A Lancet Haematology Commission published findings on the diagnosis gap for bleeding disorders in women. Average time from symptom onset to diagnosis: 14 to 16 years. For men: approximately two years.
The gap exists because bleeding disorders were historically studied in male patients. Women present differently. Heavy menstrual bleeding — affecting up to one in three women with an underlying disorder — is the most common first symptom. It is also routinely dismissed as a normal variation.
The commission is calling for this gap to be reduced to under two years by 2035. That requires point-of-care change: gynecologists, who see these patients first, need to be screening for bleeding disorders as part of the workup for menorrhagia.
The downstream costs of the current gap include unnecessary procedures, undertreated anemia, and preventable hemorrhage during childbirth and surgery.”
Stay updated with Hemostasis Today.
-
Sep 20, 2026, 13:29Factor XI Deficiency and the Challenge of Unpredictable Bleeding – EHC
-
Sep 20, 2026, 13:18Cindy Howry: FDA Approves First Treatment for Ataxia-Telangiectasia
-
Sep 20, 2026, 13:08Mohammad Salar Amoli: When Routine Coagulation Tests Miss von Willebrand Disease
-
Sep 20, 2026, 12:55Stelios Andreadis։ Human Salivary Gland Organoids Offer New Potential for Regenerative Medicine
-
Sep 20, 2026, 12:43Obi Light Ogbonnia: The Power of Lived Experience in Sickle Cell Care
-
Sep 20, 2026, 12:34Sabrine Mekni: Advancing HSCT for Children With Fanconi Anemia
-
Sep 20, 2026, 12:11Giacomo Buso: Silent Atherosclerosis Begins Earlier Than Expected
-
Sep 20, 2026, 12:0310 Posts Not to Miss This Week
-
Sep 20, 2026, 11:27Edward Lee Carter: Prasugrel Dosing Matters in P2Y12 Inhibitor Comparisons After PCI